Trending
- Costly loans loom large as Kenya’s Central Bank hikes rate to 12.5 per cent
- Falling commodity prices dampen Zimbabwe’s 2024 economic growth prospects
- Youth-led African enterprises awarded $800,000 at COP28 for climate solutions
- Kenya’s Bluewave Insurance readies entry into five African markets in $6 million plan
- The UAE Banks Federation plans to raise $270 billion in sustainable finance by 2030
- Africa must own carbon offsets value chain amid market failures
- Opportunities for South Africa in becoming the medical tourism hub of the SADC region
- Acquisitions that reshaped Zimbabwe’s banking sector in 2023
Browsing: Amref
Tuberculosis and Malaria have been a thorn in the flesh of the country’s health sector.
This is why Amref Health Africa in Kenya has signed a Global Fund Tuberculosis and Malaria grant of Ksh 7.6 billion ($70,416,010).
The fund will be split into two portions: towards control of TB a total of (KES 5.6 billion) ($51,875,868) has been set aside, and to control Malaria (KES 1.8 billion) ($16,674,386) has been earmarked.
According to information from Amref, this is a 3-year project that is set to be implemented between the year 2021 and 2024 with the help of implementing partners.
Kenya’s ministry of health says that TB remains a global and national public health concern. Globally, 104 million people are infected with TB of which nearly 1.5 million die each year. In Kenya, TB is the fifth leading cause of death. In 2019, Kenya reported and treated 86,504 cases of TB …
KBL, through the Water of Life Programme, has managed to impact over 2.5 million lives in Kenya.…